Study Sponsor: Pfizer
Phase: Phase II, Safety and Efficacy
Clinical Sites in NC: Wake Forest
The purpose of the study is to find out if the investigational drug PF-02545920 is safe and if it will have beneficial effects in participants with Huntington’s disease. The study will measure the safety and effects of a new drug on movements, mental abilities and behavior in people with Huntington’s disease.